Plus therapeutics announces the appointment of industry veteran, norman lafrance, m.d., as the company's chief medical officer

Austin, texas, sept. 13, 2021 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced the appointment of norman lafrance, m.d. to the position of chief medical officer and senior vice president.
PSTV Ratings Summary
PSTV Quant Ranking